Tag
NASDAQ: GRAL
- bioAffinity Technologies reports more than 1,620 CyPath Lung tests
- GRAIL gets 7‑2 FDA panel backing for Galleri cancer test
- GRAIL jumps 34% as FDA staff raise no major concerns on Galleri cancer test
- New treatments and detection technologies reshape lung cancer care
- FDA panel to review GRAIL's Galleri multi-cancer blood test in September
- Robotic lung biopsy system brings earlier cancer detection closer to patients
- Canadian trial to test blood-based cancer detection in 7,000 survivors
- Emerging biomarkers may improve early colorectal cancer detection and treatment monitoring
- Lung cancer innovations showcased at ASCO 2026 as researchers pursue earlier detection
- University of Manitoba researchers develop dual-mode breast cancer imaging system
- AI‑designed drugs near human trials as AlphaFold enters clinical phase
- New blood test approach could detect multiple cancers earlier, researchers say
- Guardant Health launches multi-cancer blood test in Asia through Manulife partnership
- Tango Therapeutics rallies after oncology drug collaboration with Erasca
- Oregon State nanomaterial eradicates breast cancer tumours in mice
- The year 2025 in review: A Mugglehead roundup
- The next front against cancer: A Mugglehead roundup
- Robotic-assisted bronchoscopy aids early diagnosis for lung cancer patients
- Artificial intelligence boosts accuracy of pancreatic cancer diagnosis
- Exact Sciences joins Abbott, shares soar 18% on acquisition and growth prospects
- Lung cancer awareness month: a Mugglehead roundup
- BioMark Diagnostics pushes for equitable access to early-stage lung cancer testing
- Galleri shows promise in large U.S. based clinical trial
- Evaxion shares spike as AI‑designed melanoma vaccine data hits market
- McMaster surgeon develops AI tool to reduce invasive lung biopsies
- University of Warwick uses diamonds to help trace metastasis in cancer
- University of Kentucky mobile cancer clinic enables diagnosis and treatment in a single visit
- The NHS in England introduces innovative new cancer detection options
- Breath tests could soon become key diagnosis tool for multiple diseases
- AstraZeneca and AI startup join forces in the fight against lung cancer
- Smokers skipping lung cancer screenings: study
- Grail shares jump on partnership with Quest Diagnostics
- New blood test capable of screening for over 50 cancers available in Canada